Literature DB >> 21457560

Ocular coherence tomography of symptomatic phototoxic retinopathy after cataract surgery: a case report.

Ahmad M Mansour1, Muhammad H Yunis, Walid A Medawar.   

Abstract

INTRODUCTION: High-resolution ocular coherence computed tomography enables unprecedented visualization of the retinal microarchitecture. To the best of our knowledge, this is the first report of high-resolution ocular coherence tomography findings in the healed form of photic post-cataract retinopathy. CASE
PRESENTATION: A 76-year-old Caucasian man complained of paracentral scotoma, persisting for six weeks after cataract surgery.
CONCLUSION: Ocular coherence tomography demonstrated a localized juxta-foveal area of retinal atrophy involving the photoreceptor layer, and the retinal pigment epithelium layer.

Entities:  

Year:  2011        PMID: 21457560      PMCID: PMC3077338          DOI: 10.1186/1752-1947-5-133

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  5 in total

Review 1.  Operating microscope-induced retinal phototoxicity: pathophysiology, clinical manifestations and prevention.

Authors:  M Michels; P Sternberg
Journal:  Surv Ophthalmol       Date:  1990 Jan-Feb       Impact factor: 6.048

2.  Microscope-induced retinal phototoxicity in cataract surgery of short duration.

Authors:  Guy Kleinmann; Peter Hoffman; Edna Schechtman; Ayala Pollack
Journal:  Ophthalmology       Date:  2002-02       Impact factor: 12.079

3.  Presumed photic retinopathy after cataract surgery: an angiographic study.

Authors:  J E Gomolin; R K Koenekoop
Journal:  Can J Ophthalmol       Date:  1993-08       Impact factor: 1.882

4.  Prospective incidence of photic maculopathy after cataract surgery.

Authors:  G A Byrnes; B Chang; I Loose; S A Miller; W E Benson
Journal:  Am J Ophthalmol       Date:  1995-02       Impact factor: 5.258

5.  [Optical coherence tomography and macular phototoxicity].

Authors:  N A Rodríguez-Marco; J Andonegui-Navarro; E Compains-Silva; A Rebollo-Aguayo; D Aliseda-Pérez-de-Madrid; M Aranguren-Laflin
Journal:  Arch Soc Esp Oftalmol       Date:  2008-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.